New Developments in the Treatment of Primary Biliary Cholangitis &Ndash; Role of Obeticholic Acid

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s113052
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Long-Term Clinical Impact and Cost-Effectiveness of Obeticholic Acid for the Treatment of Primary Biliary Cholangitis

Hepatology
MedicineHepatology
2017English

Primary Biliary Cholangitis: From Diagnosis to Treatment

Annals of Gastroenterology and the Digestive System
2018English

Primary Biliary Cholangitis: An Update on Treatment

Gastrointestinal Nursing
Surgical NursingMedicalSpecialized NursingAdvanced
2019English

Cost Effectiveness of Using Ursodeoxycholic Acid to Treat Primary Biliary Cholangitis

British journal of hospital medicine (London, England : 2005)
Medicine
2018English

microRevolution in Understanding Primary Biliary Cholangitis Pathophysiology

Hepatology
MedicineHepatology
2018English

Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis

Journal of Immunology Research
MedicineAllergyImmunology
2017English

Genetics and Epigenetics in the Pathogenesis of Primary Biliary Cholangitis

Clinical Journal of Gastroenterology
MedicineGastroenterology
2017English

Changing Nomenclature for PBC From “Primary Biliary Cirrhosis” to “Primary Biliary Cholangitis”

Journal of Gastroenterology
Gastroenterology
2016English

The British Society of Gastroenterology/Uk-PBC Primary Biliary Cholangitis Treatment and Management Guidelines

Gut
Gastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy